Public Access at JAMA Network
Read our policy on Public Access in this Editorial.
Research published in JAMA is free to read online 6 months after publication date and is available in PubMed Central (PMC).
Research published in one of the JAMA Network Specialty Journals is free to read online 12 months after publication date and is available in PubMed Central (PMC).
Open Access at JAMA Network
Among the critical objectives of the JAMA Network is to publish and disseminate research, review, and opinion of the highest quality to a global audience. Our commitment to open access affirms this goal by making our content discoverable, widely disseminated and accessible, and free for everyone to read.
Authors who wish to publish research articles in JAMA Network journals will be offered a Creative Commons (CC) license in exchange for payment of an article processing charge. The CC licenses, often required by funders, allow authors to retain copyright of their research articles.
Information provided by the author during the submission process will determine the appropriate CC license. Most authors will receive a CC-BY license, which offers the broadest reuse rights. Authors who report a commercial funding source will receive a CC-BY-NC-ND license.
- CC-BY License: Permits others to distribute, remix, tweak, and build on the work, even commercially, without permission, provided that credit is given to the original authors and journal.
- CC-BY-NC-ND License: Permits others to distribute the work without permission, provided that credit is given to the original authors and journal and that the article is not altered or used commercially.
Choose a journal below to learn more about the journal’s article processing charge and which types of articles are eligible for open access.
JAMA does not offer the option to publish an article under an open access license. Research published in JAMA is free to read 6 months online after publication date and is available in PubMed Central (PMC).
Article processing charges (APCs) may be reduced or waived, based on the country of residence of the corresponding author. Waivers and discounts are available for authors from a core list of countries in the developing world as defined by the World Health Organization as part of their Research4Life program. The list of countries, updated yearly, is available here.
If a manuscript is accepted for publication, authors from Group B countries will see the APC reduced by 50% and authors from Group A countries will have the APC completely waived. Authors who are eligible for this program will be informed of the APC reduction or waiver during the submission process.